​

Oruka Therapeutics Ownership | Who Owns Oruka Therapeutics?

OverviewForecastChart

Oruka Therapeutics Ownership Summary

Oruka Therapeutics is owned by 27.14% institutional investors, 3.57% insiders, and 69.29% retail investors. Fmr is the largest institutional shareholder, holding 17.18% of ORKA shares.

ORKA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOruka Therapeutics27.14%3.57%69.29%
SectorHealthcare Stocks 232.52%10.72%-143.24%
IndustryBiotech Stocks 384.56%10.59%-295.14%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr7.26M17.18%$139.56M
Vr adviser4.15M9.82%$79.77M
Fairmount funds management3.71M8.77%$71.25M
Blackrock funding, inc. /de3.54M8.03%$107.28M
Viking global investors lp2.67M6.31%$51.28M
Deep track capital, lp2.65M6.29%$51.05M
Vanguard group2.45M5.57%$74.37M
Rtw investments, lp1.95M4.61%$37.41M
Commodore capital lp1.75M4.15%$33.71M
Braidwell lp1.38M3.27%$26.58M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Fairmount funds management3.71M6.41%$71.25M
Vr adviser4.15M4.49%$79.77M
Cable car capital500.00K4.12%$9.62M
Avidity partners management lp660.42K2.89%$12.70M
Sr one capital management, lp430.33K1.85%$13.04M
Commodore capital lp1.75M1.65%$33.71M
Affinity asset advisors959.18K1.61%$18.45M
Great point partners183.33K1.45%$3.53M
Synergy asset management458.95K1.45%$13.91M
Deep track capital, lp2.65M1.42%$51.05M

Top Buyers

HolderShares% AssetsChange
Viking global investors lp2.67M0.13%2.67M
Fmr7.26M0.01%1.64M
Blackrock funding, inc. /de3.54M0.00%1.33M
Avoro capital advisors1.33M0.33%1.33M
Perceptive advisors1.27M0.70%1.27M

Top Sellers

HolderShares% AssetsChange
Janus henderson group---849.41K
Paradigm biocapital advisors lp---819.66K
Frazier life sciences management---583.33K
Redmile group---386.96K
Driehaus capital management---308.80K

New Positions

HolderShares% AssetsChangeValue
Viking global investors lp2.67M0.13%2.67M$51.28M
Avoro capital advisors1.33M0.33%1.33M$25.64M
Perceptive advisors1.27M0.70%1.27M$24.38M
Cormorant asset management, lp533.34K0.71%533.34K$10.26M
Synergy asset management458.95K1.45%458.95K$13.91M

Sold Out

HolderChange
Sbi securities-6.00
Rise advisors-36.00
Srs capital advisors-72.00
Coldstream capital management-180.00
Simplex trading-729.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202562-43.12%11,958,114-73.75%270.23%45-28.57%4-82.61%
Sep 30, 202542-48.15%6,253,192-81.84%140.22%25-51.92%9-35.71%
Jun 30, 20258017.65%34,421,52522.70%811.80%5320.45%1427.27%
Mar 31, 2025707.69%31,776,5352.46%761.28%44-8.33%1137.50%
Dec 31, 20246657.14%31,038,32126.38%770.29%4916.67%8-

Recent Insider Transactions

DateNameRoleActivityValue
Feb 17, 2026Goncalves Joana Chief Medical OfficerSell$195.87K
Feb 17, 2026Goncalves Joana Chief Medical OfficerSell$30.69K
Jan 15, 2026Goncalves Joana Chief Medical OfficerSell$138.28K
Jan 15, 2026Goncalves Joana Chief Medical OfficerSell$84.43K
Jan 02, 2026Sandler Laura Lee Chief Operating OfficerSell$246.40K

Insider Transactions Trends

DateBuySell
2026 Q1-7
2025 Q4-4
2025 Q3--
2025 Q2--
2025 Q15-

ORKA Ownership FAQ

Who Owns Oruka Therapeutics?

Oruka Therapeutics shareholders are primarily institutional investors at 27.14%, followed by 3.57% insiders and 69.29% retail investors. The average institutional ownership in Oruka Therapeutics's industry, Biotech Stocks , is 384.56%, which Oruka Therapeutics falls below.

Who owns the most shares of Oruka Therapeutics?

Oruka Therapeutics’s largest shareholders are Fmr (7.26M shares, 17.18%), Vr adviser (4.15M shares, 9.82%), and Fairmount funds management (3.71M shares, 8.77%). Together, they hold 35.78% of Oruka Therapeutics’s total shares outstanding.

Does Blackrock own Oruka Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Oruka Therapeutics.

Who is Oruka Therapeutics’s biggest shareholder by percentage of total assets invested?

Fairmount funds management is Oruka Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.41% of its assets in 3.71M Oruka Therapeutics shares, valued at 71.25M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools